Opko Health Inc Stock News

OPKO Health's (OPK) first-quarter results benefit from increase in RAYALDEE prescriptions.

BioReference Laboratories, Inc., an OPKO Health company (NASDAQ:OPK), today announced the launch of COVID-19 antibody screening available to New York City residents in partnership with New York City H

What happened After reporting a year-over-year decline in revenue that was worse than industry watchers expected, OPKO Health (NASDAQ: OPK) saw its shares fall 16.7% on Thursday. So what Although t

OPKO Health (NASDAQ: OPK) lost more than half its value last year, but so far in 2020, the stock has soared more than 40%. Here are the highlights from OPKO's Q1 update. The good news is that OPKO'

Q1 2020 OPKO Health Inc Earnings Call

Call end: 17:12 OPKO Health, Inc. (NASDAQ:OPK) Q1 2020 Earnings Conference Call May 6, 2020 4:30 PM ET Company Participants Yvonne Briggs - LHA IR Phillip Frost

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs May 6.) Adverum Biotechnologies Inc...

MIAMI, May 06, 2020 -- OPKO Health, Inc. (NASDAQ: OPK) reports business highlights and financial results for the three months ended March 31, 2020. Business Highlights.

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peak (Biotech Stocks Hitting 52-week Highs May 5) • Adverum Biotechnologies...

Israel stocks higher at close of trade; TA 35 up 2.05%

OPKO Health's (OPK) first-quarter performance is likely to reflect solid performance from Products and RAYALDEE.

Israel stocks lower at close of trade; TA 35 down 1.22%

Strong gains in April pushed the health care sector near year highs on hopes for new Covid treatments.

MIAMI, April 30, 2020 -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2020, as well as discuss financial.